Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome

NCT02303171 is registered in ClinicalTrials.gov with Mohamed Sayed Abdelhafez as lead sponsor.

NCT NCT02303171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02303171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome
Lead sponsor
Mohamed Sayed Abdelhafez
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2014
Completion date
June 30, 2025
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome, recurrent miscarriage